首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1845760

全球動脈粥狀硬化斑塊切除術設備市場規模（按類型、應用、最終用戶、區域範圍和預測）

Global Atherectomy Devices Market Size By Type, By Application, By End User (Ambulatory Surgical Centers, Hospitals), By Geographic Scope And Forecast

出版日期: 2025年09月15日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

動脈粥狀硬化斑塊切除術設備的市場規模與預測

預計 2024 年動脈粥狀硬化斑塊切除術設備市場規模將達到 16.3 億美元，2031 年將達到 25.4 億美元，2024 年至 2031 年的複合年成長率為 6.25%。

動脈粥狀硬化斑塊動脈粥狀硬化斑塊切除術器械是專門設計用於去除動脈壁斑塊並改善動脈粥樣硬化患者血流的醫療器械。這些器械透過切割、磨除或汽化導致動脈狹窄或阻塞的斑塊來發揮作用，尤其適用於周邊動脈疾病和冠狀動脈疾病。動脈粥狀硬化動脈粥狀硬化斑塊切除術通常為微創手術，並與其他治療方法（例如血管成形術和斑塊置入術）合併使用。動脈粥狀硬化斑塊動脈粥狀硬化斑塊切除術對於治療鈣化斑塊或硬斑塊非常有效，因為這些斑塊單靠傳統的球囊血管成形術難以處理。

由於心血管疾病盛行率上升、人口老化以及設備技術的進步，全球動脈粥狀硬化斑塊切除術設備市場預計將顯著成長。影像和導航技術的新發展，以及對微創手術的需求，預計將推動該領域的創新。

新興市場對動脈粥狀硬化斑塊切除術的日益普及、醫療基礎設施的改善以及優惠的報銷政策，預計將擴大這些設備的覆蓋範圍和可及性。更高的準確性、更佳的安全性以及與人工智慧診斷技術的整合，也是動脈粥狀硬化斑塊切除術設備未來發展的光明方向。

全球動脈動脈粥狀硬化斑塊切除術設備市場動態

影響全球動脈粥狀硬化斑塊切除術硬化斑塊切除設備市場的關鍵市場動態是：

關鍵市場促進因素

周邊動脈疾病(PAD) 盛行率上升：PAD 發生率的上升是動脈粥狀硬化斑塊切除術器械市場的主要驅動力。根據美國美國650 萬 40 歲及以上人口患有 PAD。 PAD 的盛行率隨著年齡成長而上升，在 60 歲及以上人群中，PAD 的盛行率高達 12% 至 20%。患者群體的不斷成長使得對動脈粥狀硬化斑塊切除器械等有效治療方案的需求日益迫切。

微創手術的普及率不斷提高：人們對微創治療的偏好日益成長，推動了對斑塊動脈粥狀硬化斑塊切除術器械的需求。血管外科學會報告稱，過去十年，包括動脈粥狀硬化斑塊切除術在內的血管內手術增加了30%。這一趨勢的動力源於微創技術帶來的住院時間縮短、併發症減少以及恢復時間加快。

動脈粥狀硬化斑塊切除術設備的技術進步：動脈粥狀硬化斑塊動脈粥狀硬化斑塊切除術技術的持續創新正在推動市場發展。美國心臟協會報告稱，與傳統方法相比，藥物塗層球囊血管成形術合併動脈粥狀硬化斑塊切除術硬化斑塊切除術可將再血管再阻塞率降低50%。這種療效的提升正推動先進動脈粥狀動脈粥狀硬化斑塊切除術術設備在醫院和門診病人的普及。

主要挑戰

設備和手術高成本：動脈粥狀硬化斑塊切除設備及相關手術價格昂貴，限制了低收入地區和無健保患者的普及。高昂的設備成本以及對熟練操作人員的需求，加重了醫療機構的財務負擔。在某些地區，報銷政策的不完善進一步加劇了這項挑戰，使醫院難以廣泛採用這些設備。這些設備的成本效益較低，尤其是與血管成形術和置入術等替代治療方法相比，這也阻礙了它們在成本敏感市場的廣泛接受。

手術複雜性：由於斑塊清除手術極為精細，尤其是在複雜或鈣化動脈阻塞的情況下，動脈粥狀硬化斑塊切除術術需要醫護人員具備高超的技能和豐富的經驗。手術過程中的任何錯誤都可能導致動脈穿孔或斑塊栓塞等併發症，給患者帶來重大風險。這種複雜性使得許多醫療機構，尤其是開發中地區的醫療機構，不願意採用這種手術。

報銷政策有限：在許多國家，切除術的保險報銷框架不如血管成形術等傳統治療的保險報銷框架全面。這種覆蓋範圍的缺失給醫療服務提供者和患者都帶來了經濟負擔。即使有報銷，也可能無法覆蓋手術的全部費用，從而阻礙了醫院投資必要的設備。報銷政策的地區差異，也給尋求在多個國家銷售動脈粥狀硬化斑塊切除術硬化斑塊切除術設備的全球製造商帶來了額外的挑戰。

主要趨勢：

即時分析需求日益成長：隨著決策越來越依賴即時數據，記憶體內變得至關重要。這些資料庫透過將資料直接儲存在RAM中，實現了超高速資料搜尋和處理，無需使用速度較慢的磁碟儲存。金融、電子商務和通訊等行業需要即時分析來做出即時決策並提高營運效率。對即時資料處理日益成長的需求預計將推動對記憶體內的需求，尤其是在高頻交易、詐欺偵測和個人化客戶體驗領域。

記憶體內運算在巨量資料中的應用：巨量資料的快速成長推動了記憶體內運算(IMC) 的廣泛應用。傳統的基於磁碟的資料庫難以即時處理和分析海量資料集，而記憶體內能夠快速存取和分析海量資料。記憶體資料庫 (IMDB) 顯著降低了巨量資料分析的延遲，從而更快獲得洞察，幫助企業做出更明智的決策。這在醫療保健、零售和物聯網等行業尤其重要，這些行業需要快速處理大量數據以獲得切實可行的洞察。

雲端基礎的記憶體內使用率不斷成長：隨著企業將其資料基礎設施遷移到雲端環境，雲端技術的採用正在推動記憶體內資料庫市場的成長。與本地解決方案相比，雲端基礎的記憶體內具有更高的擴充性、靈活性和成本效益。它們還能實現更快的資源配置和按需資源擴展，這對於工作負載波動的企業至關重要。向雲端運算的轉變正在推動企業採用記憶體內，以更靈活、更經濟的方式充分利用高速資料處理的優勢。

動脈粥狀硬化斑塊切除術切除設備全球市場概況

骨腫瘤和骨髓炎等整形外科疾病的發生率上升正在推動市場擴張。動脈粥狀硬化斑塊切除術器械最常見的用途是治療持續性骨髓炎。運動傷害和其他創傷、骨折和骨骼病變的增加預計將在未來刺激市場擴張。冠狀動脈疾病 (CAD) 和周邊動脈疾病(PAD) 盛行率的上升預計將推動動脈粥狀硬化斑塊切除術器械市場的發展。動脈粥狀硬化斑塊切除術器械在周邊動脈疾病(PAD) 的診斷和治療中發揮重要作用。

與傳統治療方法相比，該設備具有許多優勢，例如併發症風險更低、手術舒適度更高。雷射動脈粥狀硬化斑塊切除術設備的快速普及預計將推動市場成長。與機械系統相比，該設備也具有許多優勢，例如功能更豐富、效率更高，且無需使用栓塞保護裝置。

此外，雷射植入式動脈粥狀動脈粥狀硬化斑塊切除術術設備可以清除血栓、溶解促凝血反應物，並在不損傷周圍組織的情況下切除底層斑塊。因此，預計未來幾年雷射動脈粥狀動脈粥狀硬化斑塊切除術設備的使用將推動市場發展。未來幾年，對技術發展的日益重視預計將推動市場發展。

此外，支持醫療基礎設施快速擴張的強勁研究很可能在整個預測期內推動市場成長。低度開發國家的人們對易於獲取的疾病診斷和治療方法的了解有限，預計這將在未來幾年限制市場成長。此外，訓練有素的外科醫生短缺預計將在預測期內抑制市場成長。

Atherectomy devices are specialized medical instruments designed to remove plaque from the walls of arteries, improving blood flow in patients suffering from atherosclerosis. These devices work by cutting, grinding, or vaporizing arterial plaque that narrows or blocks the arteries, particularly in peripheral or coronary artery disease. Atherectomy procedures are often minimally invasive and are used in combination with other interventions such as angioplasty or stenting. They are highly valuable for treating calcified or hard plaque that is difficult to manage with conventional balloon angioplasty alone.

The global market for atherectomy devices is expected to grow significantly due to rising cardiovascular disease prevalence, an aging population, and advancements in device technology. New developments in imaging and navigation technologies, along with the demand for less invasive procedures, are expected to drive innovation in this field.

The increasing adoption of atherectomy procedures in emerging markets, improved healthcare infrastructure, and favorable reimbursement policies are likely to expand the scope and accessibility of these devices. Enhanced precision, better safety profiles, and integration with AI-powered diagnostics are also promising directions for the future of atherectomy devices.

Global Atherectomy Devices Market Dynamics

The key market dynamics that are shaping the global atherectomy devices market include:

Key Market Drivers:

Rising Prevalence of Peripheral Artery Disease (PAD): The increasing incidence of PAD is a major driver for the atherectomy devices market. According to the Centers for Disease Control and Prevention (CDC), approximately 6.5 million people aged 40 and older in the United States have PAD. The prevalence of PAD increases with age, affecting 12-20% of individuals over 60 years old. This growing patient population necessitates effective treatment options like atherectomy devices.

Increasing Adoption of Minimally Invasive Procedures: There's a growing preference for minimally invasive treatments, which is boosting the demand for atherectomy devices. The Society for Vascular Surgery reports that endovascular procedures, including atherectomy, have increased by 30% over the past decade. This trend is driven by shorter hospital stays, reduced complications, and faster recovery times associated with minimally invasive techniques.

Technological Advancements in Atherectomy Devices: Ongoing innovations in atherectomy technology are expanding the market. According to a report by the American Heart Association, the use of drug-coated balloon angioplasty in conjunction with atherectomy has shown a 50% reduction in restenosis rates compared to traditional methods. This improved efficacy is driving the adoption of advanced atherectomy devices in both hospitals and outpatient settings.

Key Challenges:

High Cost of Devices and Procedures: Atherectomy devices and the associated procedures are expensive, limiting their accessibility in low-income regions and for uninsured patients. High equipment costs, along with the need for highly skilled operators, increase the financial burden on healthcare providers. In some regions, inadequate reimbursement policies further add to the challenges, making it difficult for hospitals to adopt these devices widely. The lack of cost-effectiveness, especially when compared to alternative treatment methods like angioplasty or stenting, hampers their broader acceptance in cost-sensitive markets.

Complexity of Procedures: Atherectomy procedures require a high level of skill and experience from healthcare professionals, particularly due to the delicate nature of plaque removal in complex or calcified arterial blockages. Any error during the procedure can lead to complications, such as arterial perforation or plaque embolization, posing a significant risk to the patient. This complexity deters many healthcare facilities, especially in developing regions, from adopting the procedure.

Limited Reimbursement Policies: In many countries, the reimbursement framework for atherectomy procedures is not as comprehensive as it is for more traditional treatments like angioplasty. This lack of coverage creates financial strain on both healthcare providers and patients. Where reimbursement does exist, it may not cover the entire cost of the procedure, creating hesitancy in hospitals to invest in the necessary equipment. Varying reimbursement policies across different regions adds complexity for global manufacturers looking to market atherectomy devices in multiple countries.

Key Trends:

Growing Demand for Real-Time Analytics: With businesses increasingly relying on real-time data for decision-making, in-memory databases are becoming essential. These databases offer ultra-fast data retrieval and processing by storing data directly in RAM, eliminating the need for slower disk-based storage. Industries like finance, e-commerce, and telecom require real-time analytics to make split-second decisions, enhancing operational efficiency. As the need for instantaneous data processing grows, the demand for in-memory databases is expected to rise, especially in high-frequency trading, fraud detection, and personalized customer experiences.

Adoption of In-Memory Computing for Big Data: The proliferation of big data has led to the widespread adoption of in-memory computing (IMC). Traditional disk-based databases struggle to process and analyze massive datasets in real-time, while in-memory databases offer high-speed access and analysis, even with large volumes of data. IMDBs significantly reduce latency in big data analytics, providing faster insights for better decision-making. This is particularly important in industries like healthcare, retail, and IoT, where vast amounts of data need to be processed quickly to gain actionable insights.

Rising Use of Cloud-Based In-Memory Databases: Cloud adoption is accelerating the growth of the in-memory database market as businesses move their data infrastructure to cloud environments. Cloud-based in-memory databases offer scalability, flexibility, and cost-efficiency compared to on-premises solutions. They also provide faster provisioning and the ability to scale resources on demand, which is crucial for businesses with fluctuating workloads. The shift to cloud computing is driving organizations to adopt in-memory databases to take advantage of high-speed data processing in a more flexible and cost-effective manner.

Global Atherectomy Devices Market Overview

The increased occurrence of orthopedic illnesses such as bone tumors and osteomyelitis is driving market expansion. The most prevalent application of atherectomy devices is to treat persistent osteomyelitis. The increase in sports injuries and other types of trauma, bone fractures, and bone lesions is projected to fuel market expansion in the future. The increasing prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD) is likely to drive the Atherectomy Devices market. Atherectomy devices play a significant role in the diagnosis and treatment of peripheral artery disease (PAD).

When compared to traditional therapies, the devices provide various advantages, including a lower risk of problems and a higher degree of comfort during surgery. The rapidly increasing usage of Laser Atherectomy Devices is expected to fuel market growth. When compared to mechanical systems, these systems provide various advantages, including more versatility, increased efficiency, and the removal of the requirement for embolic protective devices.

Furthermore, laser-embedded atherectomy devices can remove thrombi, dissolve procoagulant reactants, and debulk the underlying plaque without causing damage to the surrounding tissue. As a result, the increased use of laser atherectomy devices is projected to boost the market in the coming years. The growing emphasis on technology developments is expected to boost the market in the coming years.

In addition, substantial research supporting the fast expansion of medical infrastructure is likely to boost market growth throughout the forecast period. People in underdeveloped nations have limited knowledge of the ease with which disease diagnostics and treatments are available, which is predicted to limit market growth in the coming years. Furthermore, a shortage of trained surgeons is projected to constrain market growth during the forecasted period.

Global Atherectomy Devices Market Regional Analysis

Here is a more detailed regional analysis of the global atherectomy devices market:

North America:

North America leads the global atherectomy devices market due to a high prevalence of cardiovascular diseases, especially peripheral artery disease (PAD). In the United States alone, around 8.5 million people are affected by PAD, with 12-20% of individuals over the age of 60 suffering from the condition, as reported by the CDC. As cardiovascular disease rates continue to rise, with the American Heart Association projecting that 43.9% of the U.S. population will be affected by 2030, the demand for advanced treatment options like atherectomy devices is growing. The region's healthcare systems are well-equipped to handle this demand, and the increasing burden of cardiovascular disease is a key driver behind the market's growth.

North America's strong healthcare infrastructure and rapid adoption of advanced medical technologies are major factors supporting market dominance. The number of endovascular procedures, including atherectomy, has surged by 40% over the past five years, driven by technological advancements and improved patient outcomes. Favorable reimbursement policies are also fueling this growth. Medicare has increased atherectomy reimbursement rates by 15% since 2020, and projections suggest a 7% annual rise in reimbursement for minimally invasive vascular procedures over the next three years.

Asia Pacific:

The Asia Pacific region is experiencing rapid growth in the atherectomy devices market, driven primarily by the rising prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD). According to the World Health Organization (WHO), cardiovascular diseases account for 31% of all deaths in the Western Pacific region, and this figure is expected to rise. The Asia Pacific Society of Cardiology reports a 28% increase in PAD cases over the past decade, with 54 million people affected in 2020, projected to reach 70 million by 2030. The region's aging population further amplifies this trend, as the United Nations predicts that by 2050, one in four people in Asia Pacific will be over the age of 60. This demographic shift is contributing to a growing demand for advanced cardiovascular treatments like atherectomy devices.

The region's improving healthcare infrastructure and increasing healthcare expenditure are key factors driving market growth. Healthcare spending in Asia Pacific has been growing at an average annual rate of 6.5% since 2015, surpassing global averages. This trend is expected to accelerate, with an 8% annual increase projected over the next five years, enabling the adoption of advanced medical technologies such as atherectomy devices.

The rising awareness of minimally invasive procedures has fueled the demand for atherectomy devices. A significant increase in minimally invasive vascular procedures, particularly atherectomy, has been observed across major Asian countries, with a 45% growth between 2018 and 2022. This trend is forecasted to continue, with a projected 60% rise in atherectomy procedures by 2028, further driving the market in the Asia Pacific region.

Global Atherectomy Devices Market: Segmentation Analysis

The Global Atherectomy Devices Market is Segmented on the basis of Type, Application, End User, And Geography.

Atherectomy Devices Market, By Type

Rotational Atherectomy Devices

Directional Atherectomy Devices

Based on Type, the market is fragmented Rotational Atherectomy Devices, Directional, and Atherectomy Devices. Rotational atherectomy devices are currently dominating due to their effectiveness in treating calcified lesions, which are often challenging to manage with other techniques. These devices utilize a rotating diamond-coated burr to remove plaque from arterial walls, making them particularly valuable in complex cases and contributing to their widespread adoption among healthcare providers. Directional atherectomy devices are rapidly growing in popularity, driven by their ability to selectively remove atheromatous material while preserving healthy vascular tissue. As the demand for less invasive and more precise treatment options increases, the directional atherectomy segment is expected to expand significantly, appealing to both physicians and patients seeking optimal outcomes with minimal complications.

Atherectomy Devices Market, By Application

Cardiovascular Applications

Peripheral Vascular Applications

Based on Application, the market is divided into Cardiovascular Applications and peripheral Vascular Applications. Cardiovascular applications dominate due to the high prevalence of coronary artery disease and the need for effective plaque removal techniques in managing complex cardiovascular conditions. These applications are critical as they address the urgent need for advanced treatment options, leading to increased adoption of atherectomy devices in hospitals and surgical centers. Peripheral vascular applications are rapidly growing, driven by the rising incidence of peripheral artery disease (PAD), especially among aging populations. As awareness of PAD and its associated risks increases, there is a greater demand for specialized treatments, including atherectomy procedures, to improve blood flow and alleviate symptoms, positioning this segment for significant growth in the coming years.

Atherectomy Devices Market, By End User

Ambulatory Surgical Centers (ASCs

Hospitals

Based on End User, the market is segmented into Ambulatory Surgical Centers (ASCs) and hospitals. Hospitals dominate as the primary end users due to their advanced surgical capabilities, comprehensive healthcare services, and access to specialized personnel for complex procedures. Hospitals typically handle a larger volume of patients requiring atherectomy procedures, particularly for severe cases of cardiovascular diseases, making them crucial players in this market. Ambulatory Surgical Centers (ASCs) are experiencing rapid growth, driven by the increasing trend toward outpatient procedures and the demand for minimally invasive surgeries. ASCs offer cost-effective and efficient alternatives to traditional hospital settings, attracting patients who prefer quicker recovery times and lower hospital stay durations, thus contributing significantly to the expansion of the atherectomy devices market.

Atherectomy Devices Market, By Geography

North America

Asia Pacific

Europe

Rest of the world

On the basis of geographical analysis, the atherectomy devices market is classified into North America, Asia Pacific, Europe, and Rest of the world. North America dominates the global atherectomy devices market, driven by the high prevalence of cardiovascular diseases like peripheral artery disease (PAD), well-established healthcare infrastructure, and favorable reimbursement policies. The Asia Pacific region is rapidly growing due to the increasing incidence of cardiovascular diseases, an aging population, improving healthcare infrastructure, and rising healthcare expenditures.

Key Players

The "Global Atherectomy Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic, Boston Scientific Corporation, Philips, Cardiovascular Systems Inc., Avinger Inc., Terumo Corporation, B. Braun Melsungen AG, Abbott Laboratories, Ra Medical Systems, and AngioDynamics.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Atherectomy Devices Market Recent developments
In August 2022, AngioDynamics, Inc. announced that the Auryon Atherectomy System has gained 510(k) clearance for an expanded indication that includes arterial thrombectomy.
In February 2022, RA Medical Systems announced that enrollment has reached 95 subjects in the pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease.

1 INTRODUCTION OF GLOBAL ATHERECTOMY DEVICES MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ATHERECTOMY DEVICES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT

5.1 Overview
5.2 Directional Atherectomy Systems
5.3 Orbital Atherectomy Systems
5.4 Photo-Ablative (Laser) Atherectomy Systems
5.5 Rotational Atherectomy Systems

6 GLOBAL ATHERECTOMY DEVICES MARKET, BY APPLICATION

6.1 Overview
6.2 Peripheral Vascular
6.3 Cardiovascular
6.4 Neurovascular

7 GLOBAL ATHERECTOMY DEVICES MARKET, BY END-USER

7.1 Overview
7.2 Hospitals & Surgical Centers
7.3 Research Laboratories & Academic Institutes
7.4 Ambulatory Care Centers
7.5 Others

8 GLOBAL ATHERECTOMY DEVICES MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL ATHERECTOMY DEVICES MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Boston Scientific Corporation
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Abott Laboratories
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Cardiovascular Systems Inc.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 BARD Peripheral Vascular
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Medtronic
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Straub Medical AG
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Cardinal Health
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Volcano Corporation
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments